Teatis, Inc
This is an open-label single-arm observational trial to study the effectiveness of a commercially available meal-replacement shake and its effect on the quality of life in individuals with type 2 diabetes.
Diabetes Mellitus, Type 2
Meal replacement shake
Not Applicable
Study Type : | Interventional |
Estimated Enrollment : | 100 participants |
Masking : | None (Open Label) |
Primary Purpose : | Treatment |
Official Title : | An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake. |
Actual Study Start Date : | September 15, 2022 |
Estimated Primary Completion Date : | December 30, 2022 |
Estimated Study Completion Date : | December 30, 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: Meal replacement shake Teatis meal replacement shake |
Dietary Supplement: Meal replacement shake |
Ages Eligible for Study: | 18 Years to 75 Years |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Accepts Healthy Volunteers |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Citruslabs
Santa Monica, California, United States, 90404